22 December 2023: Clinical Research
Efficacy of Continuous-Wave Transscleral Cyclophotocoagulation Post-Pars Plana Vitrectomy in Glaucoma Patients: A Retrospective Study from Poland
Izabela Kuciel-Polczak 12ABCDEF* , Magdalena Kawka-Osuch 1ABE , Katarzyna Krysik 12EF , Dariusz Dobrowolski 134DE , Dominika Janiszewska-Bil 156E , Edward Wylęgała 3DE , Beniamin Oskar Grabarek 6CE , Monika Białkowska 7F , Anita Lyssek-Boroń 128ABDEDOI: 10.12659/MSM.941770
Med Sci Monit 2023; 29:e941770
Table 1 Inclusion and exclusion criteria for the study group.
| Inclusion criteria | Exclusion criteria |
|---|---|
| 18 years old and over | Below 18 years old |
| Diagnosed glaucoma | Malignant glaucoma, closed-angle glaucoma, absolute glaucoma |
| Previous pars plana vitrectomy procedure | Previous photocoagulation of the retina |
| Provision of informed, voluntary, written consent for participation in the study | Clouding of optical media preventing high-quality OCT scans |
| Diabetic macular edema treated with anti-endothelial growth factor drugs (anti-VEGF) | |
| Other co-existing retina diseases, such as age-related macular degeneration and central retinal artery embolism/thrombosis | |
| Failure to provide informed, written consent for participation in the study | |
| Progression of optic nerve damage despite maximum doses of topical anti-glaucoma drugs | |
| No surgical treatment of glaucoma in the past (trabeculectomy, express valve implantation) |